Efficacy of Doxycycline as monotherapy or in combination with Levofloxacin in treating late-stage systemic anthrax in non-human primates
Abstract
Background: Bacillus anthracis spores pose a major biosecurity threat, in light of their use in several documented bioterror attacks and the fact that it was weaponized. The absence of specific and accurate treatment instructions in the 2001 anthrax letter attacks and the poor prognosis of patients receiving ineffective treatment emphasized the need for reliable guidelines for treating exposed (prophylaxis) or symptomatic populations. The recent 2023 CDC guidelines for treating systemic anthrax recommend a combined treatment of a tetracycline (minocycline or doxycycline) with meropenem or a fluoroquinolone. These recommendations differ from the 2001 and 2015 updates, and in the absence of significant clinical data, rely on animal studies. Previously, we demonstrated, based on a rabbit model, that these recommendations are effective in treating various stages of anthrax, ranging from post-exposure prophylaxis to systemic involvement and involvement of the CNS. Methods: We used a trigger-to-treat type of experiment using non-human primates (NHP) infected by nasal spray of a lethal dose of B. anthracis spores. Results: We confirmed our rabbit results by demonstrating the efficacy of doxycycline as a monotherapy or in combination with levofloxacin in treating late-stage systemic anthrax in non-human primates (NHP), in a trigger-to-treat type of experiment. Our experiments show high efficacy of the mono or combined therapy. Conclusions: Our results support the CDC guidelines…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.